Endoscopic sinus surgery (ESS) is a prevalent surgical procedure. It is required in many chronic rhinosinusitis for whom the medical treatment failed. In order to improve the postoperative management of patients treated with ESS, we aim to assess the analgesic action of local injection of ropivacaine in the nasal fossa.
A prospective randomized double blind placebo controlled study was designed. Local injection of ropivacaine or placebo was conducted at the end of the surgical procedure in both nasal fossa through endoscopic view in the sphenopalatine region. Pain was measured in the postoperative course with visual analogic scale in the recovery room and the rhinologic department.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
184
injection of 4mL of ropivacaine in the sphenopalatine area through an endoscopic approach
injection of 4 mL of saline solution in the sphenopalatine area through an endoscopic approach
CHRU, Hôpital Claude Huriez
Lille, France
Visual analog scale
Measure the intensity pain, in the group treated with Ropivacaine.
Time frame: at the 2 postoperative hours
Analgesics consumption orally
patient-controlled administration
Time frame: during the 7 days post-surgery
Administration of analgesics by parenteral route
patient-controlled administration
Time frame: at the 2 postoperative hours
Visual analog scale for the intensity postoperative pain
patient-controlled administration
Time frame: at the 4 and at the 6 postoperative hours
Visual analog scale for the during postoperative pain
self-assessment by the patient at home on the information collection book
Time frame: At Morning and evening between the 1 and 7 days post surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.